Cardiology Department, Heart Center, Segeberger Kliniken GmbH, Am Kurpark 1, 23795, Bad Segeberg, Germany.
Cardiology Department, Zagazig University, Sharkia, Egypt.
Clin Res Cardiol. 2024 Jul;113(7):1051-1059. doi: 10.1007/s00392-024-02434-1. Epub 2024 Mar 14.
In the PREPARE-CALC trial, severely calcified lesion preparation with rotational atherectomy (RA) before biodegradable polymer sirolimus-eluting stent (SES) implantation demonstrated higher procedural success and comparable rates of acute lumen gain and late lumen loss compared to modified balloons (MB) (scoring/cutting). We aimed to analyze the 5-year outcomes of both lesion preparation strategies.
PREPARE-CALC randomly assigned 200 patients 1:1 to MB or RA, followed by SES implantation. The principal endpoint of the current analysis was target vessel failure (TVF) at 5 years.
At 5 years, MB had comparable rates of TVF to RA (19% vs. 21%, HR 1.14, 95% CI 0.60-2.16, p = 0.687). Subgroup analysis showed a lesion length treatment interaction, favoring MB for short lesions and RA for long ones (p for interaction = 0.042). Target lesion revascularization (TLR) was significantly less common with RA (12 vs. 3%, HR 0.28, 95% CI 0.08-0.98, p = 0.048). In a multivariate analysis, RA was independently protective against TLR (adj. HR 0.17, 95% CI 0.04-0.78, p = 0.022), while ostial lesions were associated with higher TLR independent of treatment strategy (adj. HR 11.3, 95% CI 2.98-42.6, p < 0.001).
In patients with severely calcified coronary lesions, using MB or RA for lesion preparation followed by biodegradable polymer SES implantation was associated with comparable rates of TVF at 5 years. However, a significant reduction of TLR was observed after RA. PREPARE-CALC is the first randomized trial showing potential clinical advantages of RA over MB during long-term follow-up.
URL: https://www.
gov . Unique identifier: NCT02502851.
在 PREPARE-CALC 试验中,与改良球囊(MB)(切割/切割)相比,在生物可降解聚合物西罗莫司洗脱支架(SES)植入前使用旋切术(RA)对严重钙化病变进行预处理,显示出更高的手术成功率和相似的急性管腔获得率和晚期管腔丢失率。我们旨在分析两种病变准备策略的 5 年结果。
PREPARE-CALC 将 200 例患者随机分为 1:1 的 MB 或 RA 组,随后进行 SES 植入。本分析的主要终点是 5 年时的靶血管失败(TVF)。
5 年时,MB 的 TVF 率与 RA 相当(19% vs. 21%,HR 1.14,95%CI 0.60-2.16,p=0.687)。亚组分析显示病变长度治疗存在交互作用,MB 有利于短病变,RA 有利于长病变(p 交互作用=0.042)。RA 组的靶病变血运重建(TLR)明显较少(12% vs. 3%,HR 0.28,95%CI 0.08-0.98,p=0.048)。在多变量分析中,RA 独立于治疗策略具有 TLR 的保护作用(adj. HR 0.17,95%CI 0.04-0.78,p=0.022),而开口病变与 TLR 独立相关,与治疗策略无关(adj. HR 11.3,95%CI 2.98-42.6,p<0.001)。
在严重钙化的冠状动脉病变患者中,使用 MB 或 RA 进行病变准备,随后进行生物可降解聚合物 SES 植入,5 年时 TVF 发生率相当。然而,RA 后 TLR 显著减少。PREPARE-CALC 是第一个随机试验,显示 RA 在长期随访中优于 MB 的潜在临床优势。